ArticlePDF Available

The Bronchiectasis Toolbox—A Comprehensive Website for the Management of People with Bronchiectasis

Authors:

Abstract and Figures

While the health burden of bronchiectasis is increasing worldwide, medical and physiotherapy treatment strategies have progressed significantly over the past decade. For this reason, clinicians require readily accessible current evidence based information on the management of this condition. E-learning is a suitable educational forum for the development and maintenance of professional skills, however a comprehensive, evidence based, multidisciplinary website for bronchiectasis was not available. The Bronchiectasis Toolbox at www.bronchiectasis.com.au was developed by a team of clinicians in Australia and New Zealand with extensive experience in bronchiectasis. The content of this website, based on national and international guidelines, is presented under the headings: ‘Bronchiectasis’, ‘Assessment’, ‘Physiotherapy’, ‘Indigenous’, ‘Paediatrics’, and ‘Resources’. Through a blend of multimedia resources, this website provides information to consolidate the knowledge and practical skills for health professionals caring for people with this condition. After launching in 2015 the website has received 64,549 hits from over 100 countries and the videos have been viewed 10,205 times in 89 countries. The Bronchiectasis Toolbox is a comprehensive multidisciplinary resource accessible to health professionals worldwide who manage people with bronchiectasis and is a unique solution to an educational need. Regular updates will ensure that the website continues to be relevant.
Content may be subject to copyright.
medical
sciences
Communication
The Bronchiectasis Toolbox—A Comprehensive
Website for the Management of People
with Bronchiectasis
Caroline H. Nicolson 1, *, Anne E. Holland 2and Annemarie L. Lee 2
1Physiotherapy Department, The Alfred Hospital, Melbourne, 3004, Australia
2Department of Rehabilitation, Nutrition and Sport, Alfred Health Clinical School, La Trobe University;
Melbourne, 3086, Australia a.holland@latrobe.edu.au (A.E.H.); A.Lee3@latrobe.edu.au (A.L.L.)
*Correspondence: c.nicolson@alfred.org.au
Academic Editor: Eva Polverino
Received: 12 May 2017; Accepted: 7 June 2017; Published: 12 June 2017
Abstract:
While the health burden of bronchiectasis is increasing worldwide, medical and
physiotherapy treatment strategies have progressed significantly over the past decade. For this
reason, clinicians require readily accessible current evidence based information on the management
of this condition. E-learning is a suitable educational forum for the development and maintenance
of professional skills, however a comprehensive, evidence based, multidisciplinary website for
bronchiectasis was not available. The Bronchiectasis Toolbox at www.bronchiectasis.com.au was
developed by a team of clinicians in Australia and New Zealand with extensive experience
in bronchiectasis. The content of this website, based on national and international guidelines,
is presented under the headings: ‘Bronchiectasis’, ‘Assessment’, ‘Physiotherapy’, ‘Indigenous’,
‘Paediatrics’, and ‘Resources’. Through a blend of multimedia resources, this website provides
information to consolidate the knowledge and practical skills for health professionals caring for
people with this condition. After launching in 2015 the website has received 64,549 hits from over
100 countries and the videos have been viewed 10,205 times in 89 countries. The Bronchiectasis
Toolbox is a comprehensive multidisciplinary resource accessible to health professionals worldwide
who manage people with bronchiectasis and is a unique solution to an educational need. Regular
updates will ensure that the website continues to be relevant.
Keywords:
bronchiectasis; physiotherapy; airway clearance; exercise; management; antibiotics;
indigenous health
1. Introduction
Bronchiectasis is a chronic lung disease with abnormal sputum production and recurrent infections
which can significantly reduce quality of life [
1
]. The prevalence of bronchiectasis worldwide is
variable [
2
,
3
] but is known to be significantly higher amongst the Indigenous communities in Australia,
New Zealand, and Alaska [46].
Physiotherapy airway clearance techniques are integral to the management of patients with
bronchiectasis. In recent years, with the rising healthcare burden of bronchiectasis [
1
], an increasing
number of treatment options for maximising sputum clearance have become available. Positive
expiratory pressure therapy, advanced breathing strategies, and inhalation therapy are frequently the
patients’ treatment of choice [
7
10
] and the benefits of exercise and pulmonary rehabilitation in this
population have been demonstrated [
11
,
12
]. Medical management strategies have also significantly
progressed with the introduction of new regimes such as inhaled antibiotics and macrolides for people
with bronchiectasis [
13
,
14
]. Health professionals who have not recently graduated, or who are new to
Med. Sci. 2017,5, 13; doi:10.3390/medsci5020013 www.mdpi.com/journal/medsci
Med. Sci. 2017,5, 13 2 of 7
the clinical care of people with bronchiectasis, or who practice in rural or regional centres, may have
limited training in these treatment protocols. Some health professionals may be unaware of recent
advances in management, with limited access to information regarding best practice physiotherapy
and medical care. With the health burden of bronchiectasis increasing in both the non-Indigenous and
Indigenous population worldwide, with a steady rise in hospital admissions [
15
,
16
], there is a need to
ensure the most up-to-date information is readily available to all practitioners.
Comprehensive multi-media web resources are available to support health professionals caring for
people with other chronic respiratory conditions (including chronic obstructive pulmonary disease and
asthma) [
17
,
18
]. However, such resources were not available to health professionals caring for people
with bronchiectasis. This form of E-learning is optimally suited not only to health professionals working
in remote and regional areas for distance learning but also to those employed in metropolitan regions,
including medical and physiotherapy students. It is well documented that E-learning enhances and
enables effective and flexible learning for a digital generation [
19
]. The diverse modes in which material
is presented (video, audio, and written material) is designed to cater to a range of consumers’ learning
styles, to optimally facilitate learning. The goal of this website was to bridge a recognized gap in
healthcare professional education in the multidisciplinary management of people with bronchiectasis,
by developing a state-of-the-art electronic platform of information and resources.
2. Materials and Methods
A web designer was employed to develop a logo and branding and to design the site based on
the WordPress content management system with a responsive HTML5 front end which optimizes
viewing on all platforms, including mobile devices. Multi-media resources, including videos and
photographs, were produced by a professional digital media company. Consent was provided by all
participants photographed or filmed in the videos with the exception of photographs purchased from a
public website. Indigenous Respiratory Outreach Care provided access to their Aboriginal and Torres
Strait Islander health resources. To avoid copyright issues, a graphic artist was employed to create
the required diagrams. The scripts for the airway clearance videos were written by physiotherapists
with extensive experience in the management of people with bronchiectasis and in the demonstration
and teaching of physiotherapy airway clearance techniques. The selection of these techniques was
based on the current literature of airway clearance therapy in this population [
8
10
,
20
,
21
] and surveys
reflecting clinical practice [2224].
The written content of the site was developed by an ad hoc group of experienced highly
qualified healthcare professionals who have completed numerous collaborative research projects
on bronchiectasis-related issues—including exercise [
11
], nebulised medications [
10
], airway clearance
therapy [
20
,
25
], pulmonary rehabilitation [
26
,
27
], and co-morbidities in bronchiectasis [
28
] and have
contributed to national guidelines for the care of individuals with bronchiectasis [
6
]. The educational
materials were developed by the team, based on the current international [
29
] and national guidelines
for bronchiectasis [
6
] under the headings ‘Bronchiectasis’, ‘Assessment’, ‘Physiotherapy’, ‘Paediatrics’,
‘Indigenous’, and ‘Resources’ (Table 1). The Indigenous section provides information on cultural
awareness and culturally appropriate resources. It was developed, in consultation with members of
the Indigenous communities, by clinicians in Australia and New Zealand with extensive experience
in both the Aboriginal and Torres Strait Islander and Maori populations. The written material was
provided by clinicians pro bono. All material is referenced to studies in peer reviewed literature in
bronchiectasis, with relevant links to enable downloading of information as required. A home page
‘News’ section enables the regular addition of research and information relevant to bronchiectasis and
a ‘Contact Us’ section is provided to enable feedback. A legal disclaimer was included on the home
page to clarify that the site was not to be relied upon by patients as a substitute for medical advice by
their health care professional.
Med. Sci. 2017,5, 13 3 of 7
Table 1. Contents of the Bronchiectasis Toolbox.
Headings Sub Headings Content
Bronchiectasis
Bronchiectasis
Definition
Pathophysiology
Prevalence
Causes
Symptoms
Diagnosis
Importance of Diagnosis
How is it Diagnosed?
Radiology
Lung Function
Sputum Pathology
Investigations for Secondary Causes
Management
Management and Goals
Treatment Options
Identifying an Exacerbation
Action Plan
Videos of Physiotherapy Techniques
Medications for Bronchiectasis
Medications Correct Use of Medications
Order of Medications
Co-morbidities
Sinusitis
Gastro-Oesophageal Reflux
Urinary Incontinence
Musculoskeletal Issues
Living with
Bronchiectasis
Nutrition
Sleep
Travel
Prognosis
Anxiety and Depression
Assessment
Medical
Clinical Examination
Bronchiectasis Severity Index
FACED 1Score
Physiotherapy Subjective Assessment
Objective Assessment
Outcome Measures
Exacerbations
Sputum
Quality of Life Questionnaires
Lung Function
Exercise Tolerance
Physiotherapy
Principles of
Airway Clearance
Airway Clearance in the Normal Lung
Hydration and Humidification
Management Plan
Choosing a Technique
Case Study
Techniques
Videos of Physiotherapy Techniques
The Active Cycle of Breathing Technique
Forced Expiration Technique
Positive Expiratory Pressure Therapy
Oscillating Positive Expiratory Pressure Therapy
Autogenic Drainage
Gravity Assisted Drainage
Manual Techniques
Exercise
Inhalation Therapy via a Nebuliser
Why Prescribe Exercise in Bronchiectasis
Exercise Prescription
Med. Sci. 2017,5, 13 4 of 7
Table 1. Cont.
Headings Sub Headings Content
Indigenous
Cultural
Aboriginal and Torres Strait Islanders
Maori
Assessment
Medical and
Physiotherapy
Causes
Management
Action plan
Airway Clearance and Exercise
Airway Clearance Video
Resources
Useful Links
Talking Posters
Flip Charts
Posters and Pamphlets
Videos
Paediatrics
Medical
Assessment
Causes
Management
Physiotherapy
Assessment and Management
Exercise
Action Plan
Airway Clearance
Choosing the Correct Technique
Airway Clearance Video
Oscillating PEP—Bottle PEP, Acapella, Flutter
Positive Expiratory Pressure Mask
Assisted Autogenic Drainage
Forced Expiration Technique
Modified Postural Drainage
Manual Techniques
High Frequency Chest Wall Oscillation
Resources
Videos
The Active Cycle of Breathing Technique
Forced Expiration Technique
Positive Expiratory Pressure (PEP) Therapy using PARI PEP,
Mask PEP, and TheraPEP
Oscillating PEP Therapy using Acapella, Bottle PEP, Flutter
Aerobika
Autogenic Drainage
Manual Techniques
Nebuliser Therapy
Correct Use of Medications
References
Airway Clearance (other than PEP)
Bronchiectasis
Co-Morbidities
Exercise
Indigenous Health
Miscellaneous
Paediatrics
PEP Therapy
Other Resources
Useful links
Patient Handouts—Including Other Languages
Physiotherapy Assessment Forms
Action Plans
Measurement of Exercise Capacity
Purchasing Equipment
Nijmegen Questionnaire
Current Research
1
FACED score: F—forced expiratory volume, A—age, C—chronic colonisation, E—radiological
extension, D—dyspnea.
Med. Sci. 2017,5, 13 5 of 7
To maximise the exposure of the website to healthcare professionals worldwide, the Bronchiectasis
Toolbox was presented at the 1st World Bronchiectasis conference in Hannover in 2016. It was also
reviewed in the European Respiratory Society and Thoracic Society of Australia and New Zealand
newsletters in 2016. Search engine optimisation strategies were implemented for the first 18 months to
assist with prominence of the website on search engines such as Google. This included the use of ad
words and the regular addition of relevant content to the website.
3. Results
The Bronchiectasis Toolbox was launched in December 2015 at www.bronchiectasis.com.au.
In 2016, it was endorsed by the Thoracic Society of Australia and New Zealand. By May 2017 the
site had 64,549 hits from over 100 countries with the majority of users being from Australia, UK,
and USA (Figure 1). Over the same period the physiotherapy airway clearance videos had been
viewed 10,205 times in 89 countries. A Google search, using the term “bronchiectasis”, currently places
the website in first position. The airway clearance videos are being used in universities throughout
Australia as a teaching tool for undergraduate physiotherapy students. The majority of feedback from
the ‘Contact Us’ section of the website has been from patients enquiring about the management of
their condition and the purchasing of equipment which indicates that a ‘Patient’ section of the website
is desirable.
Figure 1.
Countries accessing the Bronchiectasis Toolbox. UK—United Kingdom, USA—United States
of America, NZ—New Zealand.
4. Discussion
As bronchiectasis has previously been considered an orphan disease [
30
,
31
] multidisciplinary
information on the condition and management strategies has been limited. A website which presents
information on all aspects of the condition provides a wholistic approach to the disease and its
management for clinicians in one location, an option that to date has not been available. Although
designed for health professionals (including students), clinicians can direct their patients to the
‘Resources’ section of the website to view videos of a large range of airway clearance treatment
techniques, nebuliser therapy and the correct use of medications. Health professionals can also
direct their colleagues to online videos and downloadable information on a broad selection of topics,
including the latest evidence, which has been recognised as important in the overall management of
bronchiectasis, according to the latest national [
6
] and international guidelines [
29
]. The Indigenous
resources include information on the Aboriginal and Torres Strait Islander populations in Australia.
It is hoped that an Alaskan section will be developed to be included in this section. Following feedback
from patients via the website, a ‘Patient’ section is currently being developed.
Med. Sci. 2017,5, 13 6 of 7
5. Conclusions
In conclusion, the Bronchiectasis Toolbox is a unique solution to a pressing need which has been
accessed by clinicians worldwide. Ongoing evaluation of the website will assist with the continuing
inclusion of relevant evidence based updates which will ensure that the latest information is readily
accessible in a single location, contributing to the ongoing education of health professionals caring for
this patient population.
Acknowledgments:
The authors would like to thank the health care professionals who contributed to the content
of the website.
Author Contributions:
Caroline H. Nicolson drafted the manuscript, with Anne E. Holland and Annemarie L. Lee
provided critical review.
Conflicts of Interest: The authors have no conflicts of interest to declare.
References
1.
Martínez-García, M.A.; Perpiñá-Tordera, M.; Román-Sánchez, P.; Soler-Cataluña, J.J. Quality of life
determinants in patients with clinically stable bronchiectasis. Chest
2005
,128, 739–745. [CrossRef] [PubMed]
2.
Quint, J.K.; Millett, E.R.C.; Joshi, M.; Navaratnam, V.; Thomas, S.L.; Hurst, J.R.; Smeeth, L.; Brown, J.S.
Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013:
A population-based cohort study. Eur. Respir. J. 2016,41, 186–193. [CrossRef] [PubMed]
3.
Seitz, A.E.; Olivier, K.N.; Adjemian, J.; Holland, S.M.; Prevots, D.R. Trends in bronchiectasis among medicare
beneficiaries in the United States, 2000 to 2007. Chest 2012,142, 432–439. [CrossRef] [PubMed]
4.
Singleton, R.; Morris, A.; Redding, G.; Poll, J.; Holck, P.; Martinez, P.; Kruse, D.; Bulkow, L.R.; Petersen, K.M.;
Lewis, C. Bronchiectasis in Alaska Native children: Causes and clinical courses. Pediatr. Pulmonol.
2000
,29,
182–187. [CrossRef]
5.
Singleton, R.J.; Valery, P.C.; Morris, P.; Byrnes, C.A.; Grimwood, K.; Redding, G.; Chang, A.B. Indigenous
children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.
Pediatr. Pulmonol. 2014,49, 189–200. [CrossRef] [PubMed]
6.
Chang, A.B.; Bell, S.C.; Torzillo, P.J.; King, P.T.; Maguire, G.P.; Byrnes, C.A.; Holland, A.E.; O’Mara, P.;
Grimwood, K.; extended voting group. Chronic suppurative lung disease and bronchiectasis in children and
adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med. J. Aust.
2015,202, 21–23. [CrossRef] [PubMed]
7.
Eaton, T.; Young, P.; Zeng, I.; Kolbe, J. A randomized evaluation of the acute efficacy, acceptability and
tolerability of flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis
bronchiectasis. Chronic Respir. Dis. 2007,4, 23–30. [CrossRef] [PubMed]
8.
Patterson, J.E.; Bradley, J.M.; Hewitt, O.; Bradbury, I.; Elborn, J.S. Airway clearance in bronchiectasis:
A randomized crossover trial of active cycle of breathing techniques versus Acapella. Respiration
2005
,72,
239–242. [CrossRef] [PubMed]
9.
Thompson, C.S.; Harrison, S.; Ashley, J.; Day, K.; Smith, D.L. Flutter valve or conventional physiotherapy in
productive non-cystic bronchiectasis?—A randomised crossover study. Thorax 2000,55 (Suppl. S3), A71.
10.
Nicolson, C.H.; Stirling, R.G.; Borg, B.M.; Button, B.M.; Wilson, J.W.; Holland, A.E. The long term effect of
inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis. Respir. Med.
2012
,106, 661–667. [CrossRef]
[PubMed]
11.
Lee, A.L.; Hill, C.J.; Cecins, N.; Jenkins, S.; McDonald, C.F.; Burge, A.T.; Rautela, L.; Stirling, R.G.;
Thompson, P.J.; Holland, A.E. The short and long term effects of exercise training in non-cystic fibrosis
bronchiectasis—A randomised controlled trial. Respir. Res. 2014,15, 44. [CrossRef] [PubMed]
12.
Lee, A.L.; Cecins, N.; Hill, C.J.; Holland, A.E.; Rautela, L.; Stirling, R.G.; Thompson, P.J.; McDonald, C.F.;
Jenkins, S. The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: Protocol
for a randomised controlled trial. BMC Pulm. Med. 2010,10, 5. [CrossRef] [PubMed]
13.
Fan, L.C.; Lu, H.W.; Wei, P.; Ji, X.B.; Liang, S.; Xu, J.F. Effects of long-term use of macrolides in patients with
non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials. BMC Infect. Dis.
2015
,15,
160. [CrossRef] [PubMed]
Med. Sci. 2017,5, 13 7 of 7
14.
Wilson, R.; Welte, T.; Polverino, E.; De Soyza, A.; Greville, H.; O’Donnell, A.; Alder, J.; Reimnitz, P.; Hampel, B.
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: A phase II randomised study.
Eur. Respir. J. 2013,41, 1107–1115. [CrossRef] [PubMed]
15.
Weycker, D.; Edelsberg, J.; Oster, G.; Tino, G. Prevalence and Economic Burden of Bronchiectasis.
Clin. Pulm. Med. 2005,12, 205–209. [CrossRef]
16.
McShane, P.J.; Naureckas, E.T.; Tino, G.; Strek, M.E. Non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit.
Care Med. 2013,188, 647–656. [CrossRef] [PubMed]
17.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention
©
2014. Global
Initiative for Asthma: 2014. 148. Available online: www.ginaasthma.org.http://www.who.int/respiratory/
asthma/GINA_WR_2006_copyright[1].pdf (accessed on 5 May 2017).
18.
GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis,
Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2011. Available online: http:
//www.goldcopd.org.http://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-
Guide.pdf (accessed on 5 May 2017).
19.
Andersen, R.; Ponti, M. Participatory pedagogy in an open educational course: Challenges and opportunities.
Distance Educ. 2014,35, 234–249. [CrossRef]
20.
Lee, A.L.; Williamson, H.C.; Lorensini, S.; Spencer, L.M. The effects of oscillating positive expiratory pressure
therapy in adults with stable non-cystic fibrosis bronchiectasis: A systematic review. Chronic Respir. Dis.
2015,12, 36–46. [CrossRef] [PubMed]
21.
Murray, M.P.; Pentland, J.L.; Hill, A.T. A randomised crossover trial of chest physiotherapy in non-cystic
fibrosis bronchiectasis. Eur. Respir. J. 2009,34, 1086–1092. [CrossRef] [PubMed]
22.
Butler, S.G.; Hill, L.J.; Harrison, J.; Reed, P.; Nikora, G.; Takai, C.; Byrnes, C.A.; Edwards, E.A. Is there a
difference in airway clearance practices between children with non cystic fibrosis bronchiectasis and cystic
fibrosis? N. Z. J. Physiother. 2008,36, 112–117.
23.
Lee, A.; Button, B.; Denehy, L. Current Australian and New Zealand physiotherapy practice in the
management of patients with bronchiectasis and chronic obstructive pulmonary disease. N. Z. J. Physiother.
2008,36, 49–58.
24.
O’Neill, B.; Bradley, J.M.; McArdle, N.; MacMahon, J. The current physiotherapy management of patients
with bronchiectasis: A UK survey. Int. J. Clin. Pract. 2002,56, 34–35. [PubMed]
25.
Lee, A.L.; Burge, A.T.; Holland, A.E. Airway clearance techniques for bronchiectasis. Cochrane Database
Syst. Rev. 2015,11. [CrossRef]
26.
Holland, A.E.; Mahal, A.; Hill, C.J.; Lee, A.L.; Burge, A.T.; Moore, R.; Nicolson, C.; O’Halloran, P.; Cox, N.S.;
Lahham, A.; et al. Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive
pulmonary disease—A multi-centre randomised controlled equivalence trial. BMC Pulm. Med.
2013
,13, 57.
[CrossRef] [PubMed]
27.
Spruit, M.A.; Singh, S.J.; Garvey, C.; ZuWallack, R.; Nici, L.; Rochester, C.; Hill, K.; Holland, A.E.; Lareau, S.C.;
Man, W.D.; et al. An official American thoracic society/European respiratory society statement: Key concepts
and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013,188. [CrossRef] [PubMed]
28.
Lee, A.L.; Button, B.M.; Denehy, L.; Roberts, S.J.; Bamford, T.L.; Ellis, S.J.; Mu, F.T.; Heine, R.G.; Stirling, R.G.;
Wilson, J.W. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and
bronchiectasis. Respirology 2014,19, 211–217. [CrossRef] [PubMed]
29.
Pasteur, M.C.; Bilton, D.; Hill, A.T. British Thoracic Society Bronchiectasis non-CF Guideline Group. British
Thoracic Society guideline for non-CF bronchiectasis. Thorax
2010
,65 (Suppl. S1), i1–i58. [CrossRef]
[PubMed]
30.
Polverino, E.; Cacheris, W.; Spencer, C.; Operschall, E.; O’Donnell, A.E. Global burden of non-cystic fibrosis
bronchiectasis: A simple epidemiological analysis. Eur. Respir. J. 2012,40, P3983.
31. O’Donnell, A.E. Bronchiectasis. Chest 2008,134, 815–823. [CrossRef] [PubMed]
©
2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
... Bronchial hygiene involved a series of exercises performed in a sitting position and designed to promote breathing control, thorax expansion after holding an inspired breath, and forceful expiration of the breath [11,12]. Each patient performed these exercises before every training session for 15-20 min. ...
... Each patient performed these exercises before every training session for 15-20 min. Patients and caregivers were also educated about postural drainage, manually assisted thoracic-abdominal compression, and controlled coughing [11,12]. A physiotherapist applied the techniques before a session if necessary. ...
Article
Introduction: Pulmonary rehabilitation (PR) is an effective approach for patients with chronic pulmonary disease, and it is also recommended for patients with bronchiectasis. The aims of the current study were to evaluate the efficacy of a multidisciplinary PR program and identify factors associated with improvement in patients with bronchiectasis. Material and ethods: We obtained data from patients with bronchiectasis who completed our PR program which consisted of education and training regarding bronchial hygiene. Pulmonary function test results, body composition, exercise capacity, quality of life, and psychological status were assessed before and after the PR program. Results: We enrolled 130 patients in this retrospective study. Most patients had a history of pneumonia. The Medical Research Council (MRC) dyspnea scale, incremental shuttle walking test (ISWT), endurance shuttle walking test (ESWT), St. George's Respiratory Questionnaire (SGRQ), Chronic Respiratory Questionnaire (CRQ), and Hospital Anxiety and Depression (HAD) scores statistically improved after the PR program (all p < 0.001). Improvements were similar regardless of sex, etiology, smoking sta-tus, or number of hospitalizations. Age was negatively correlated with ΔSGRQ (p = 0.024, r = -0.203). Baseline forced expiratory volume in 1s (FEV1) was positively correlated with ΔCRQ (p = 0.015, r = 0.213) and negatively correlated with Δanxiety (p = 0.014, r = -0.215). Baseline MRC was negatively correlated with ΔMRC (p < 0.001, r = -0.563) and ΔSGRQ (p < 0.001, r = -0.308). Baseline ISWT was negatively correlated with ΔISWT (p = 0.043, r = -0.176) and Δanxiety (p = 0.007, r = -0.237). Baseline SGRQ was negatively correlated with ΔMRC (p = 0.003, r = -0.267) and ΔSGRQ (p < 0.001, r = -0.648). Conclusions: Our PR program is efficacious for patients with bronchiectasis regardless of sex, etiologic cause of bronchiectasis, concomitant chronic obstructive pulmonary disease, smoking status, and/or number of hospitalizations. Improvement varied among patients which highlights the need for more studies to determine which patients will benefit most from the program.
... Airway clearance therapy addresses to the airway structural dysfunction with the aim to overcome the failure of mucus clearance. Active interventions include physical exercise (pulmonary rehabilitation), mucus drainage techniques, the use of mechanical devices and pharmacological therapies [29,30]. Hypertonic saline 7% improved lung function and quality of life in non-cystic fibrosis bronchiectasis patients [31], bronchodilators and N acetyl cysteine have an unknown efficacy, while mannitol and rhDNase proved to be ineffective [32,33]. ...
Article
Full-text available
In the COVID-19 pandemic year 2020, the 30th edition of the ERS Congress took place for the first time in a fully virtual format. Despite the challenging nature of the task to create and deliver an online event of this size and scope, the ERS Congress 2020 turned to be a great success, welcoming over 33 000 delegates to the specially designed online platform and offering more than 450 scientific and educational sessions. Somewhat predictable, this year's Congress dedicated a full day on COVID-19 topic, highlighting that infection with SARS-CoV-2 is a respiratory disease. In this article the Early Career Members of the Assembly 10 (Respiratory Infections and Tuberculosis) review some of the most interesting sessions including presentations and posters on respiratory infections and tuberculosis that were deemed as important.
... Online web formats can be readily accessible, free and provide rapid access to evidencebased medical information. The Bronchiectasis Toolbox 26 and Australian Asthma Handbook 27 are two examples in the respiratory field. Clinicians and medical trainees are increasingly accessing free online content to complement existing training programmes. ...
Article
Full-text available
Objectives Severe asthma imposes a significant burden on individuals, families and the healthcare system. New treatment and management approaches are emerging as effective options for severe asthma. Translating new knowledge to multidisciplinary healthcare professionals is a priority. We developed ‘The Severe Asthma Toolkit’ (https://toolkit.severeasthma.org.au ) to increase awareness of severe asthma, provide evidence-based resources and support decisionmaking by healthcare providers. Setting Roundtable discussions and a survey of Australians clinicians were conducted to determine clinician preferences, format and content for a severe asthma resource. Participants A reference group from stakeholder and consumer bodies and severe asthma experts provided advice and feedback. A multidisciplinary team of international experts was engaged to develop content. Written content was based on up-to-date literature. Peer and editorial review were performed to finalise content and inform web design. Website design focused on user experience, navigation, engagement, interactivity and tailoring of content for a clinical audience. Results A web-based resource was developed. Roundtable discussions and a needs assessment survey identified the need for dedicated severe asthma management resources to support skills training. The end-product, which launched 26 March 2018, includes an overview of severe asthma, diagnosis and assessment, management, medications, comorbidities, living with severe asthma, establishing a clinic, paediatrics/adolescents and clinical resources. Analytics indicate access by users worldwide (32 169 users from 169 countries). User survey results (n=394) confirm access by the target audience (72% health professionals), who agreed the toolkit increased their knowledge (73%) and confidence in managing severe asthma (66%), and 75% are likely to use the resource in clinic. Conclusions The Severe Asthma Toolkit is a unique, evidence-based internet resource to support healthcare professionals providing optimal care for people with severe asthma. It is a comprehensive, accessible and independent resource developed by leading severe asthma experts to improve clinician knowledge and skills in severe asthma management.
... Routine exercise is also helpful and patients may benefit from enrollment in formal pulmonary rehabilitation programs that include several exercise modalities and patient education. The "Bronchiectasis Toolbox" is a comprehensive website that provides patient instruction on airway clearance (21). Personalizing airway clearance is important in order to optimize adherence (22). ...
Article
The medical management of bronchiectasis includes confirming the diagnosis of the disease, evaluating the patient for possible underlying etiologies and then properly assessing the patient for appropriate therapies. Patients with bronchiectasis are heterogeneous and a personalized approach to each patient is needed in order to properly formulate an optimal management plan.
Article
Full-text available
Guidelines on managing chronic suppurative lung disease (CSLD) and bronchiectasis (unrelated to cystic fibrosis [CF]) in Australian Indigenous children initiated in 20021 were extended to include Indigenous adults in 20082 and children and adults living in urban areas of Australia and New Zealand in 2010.3 Here, we present an updated guideline relevant for all sections of the community. The recommendations in this guideline are targeted principally to primary and secondary care, and are not intended for individualised specialist care. As with all guidelines, they are not a substitute for sound clinical judgement, particularly when investigating and treating such a phenotypically heterogeneous condition as bronchiectasis.4
Article
Full-text available
The purpose of this study was to evaluate the clinical benefits and safety of the long-term use of macrolides in patients with non-cystic fibrosis (non-CF) bronchiectasis. Embase, Pubmed, the Cochrane Library and Web of Science databases were searched from inception up to March 2014. The primary outcome was the improvement of exacerbations of bronchiectasis. Secondary endpoints included changes of microbiology, lung function, quality of life, sputum volume, adverse events and macrolide resistance. The literature search yielded 139 studies, ten of which containing 601 patients were included in this meta-analysis. Macrolides showed a statistically-significant improvement in reducing acute exacerbations per patient during follow-up treatment (RR = 0.55, 95% CI: 0.47, 0.64, P < 0.001), increasing the number of patients free from exacerbations (OR = 2.81, 95% CI: 1.85, 4.26, P < 0.001), and prolonging time to a first exacerbation (HR = 0.38, 95% CI: 0.28, 0.53, P < 0.001). Macrolides maintenance treatment was superior to control with respect to attenuating FEV1 decline (p = 0.02), improving sputum volume (p = 0.009) and SGRQ total scores (p = 0.02), but showed a higher risk of adverse events, especially diarrhea (OR = 5.36; 95% CI: 2.06, 13.98, P = 0.0006). Eradication of pathogens was improved in the macrolide group (OR = 1.76, 95% CI: 0.91, 3.41, P = 0.09), while pathogen resistance caused by macrolides dramatically increased (OR = 16.83, 95% CI: 7.26, 38.99, P < 0.001). The new appearance of a microbiologic profile or participant withdrawal due to adverse events showed no significant differences between the two groups. In patients with non-CF bronchiectasis, macrolide maintenance treatment can effectively reduce frequency of exacerbations, attenuate lung function decline, decrease sputum volume, improve quality of life, but may be accompanied with increased adverse events (especially diarrhea) and pathogen resistance.
Article
Sputum clearance remains the mainstay of therapy in bronchiectasis. Some patients find postural drainage and the forced expiratory manoeuvre (conventional physiotherapy, CP) difficult and the VRPI flutter valve (FP) offers an alternative. Studies in cystic fibrosis and obstructive lung disease have shown the flutter to aid sputum clearance (MW Konstan et al. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994;124:689-93, UH Cegla et al. Physiotherapy with the VRPI for COPD - results of a multicenter comparative study. Pneumonol 1993;47:636-39) however a recent systematic review found that evidence for the benefit of any type of physiotherapy in non-cystic productive lung disease was inconclusive and that studies were of poor quality (A Jones, B Rowe.Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstuctive pulmonary disease: A systematic review. Heart Lung 2000;29:125-35). We have compared CP with FP in non-cystic fibrosis bronchiectasis. Fourteen stable patients (10 female, mean age 61.5 yrs) performed a month of CP and a month of FP in random order. Sputum weight and duration of physiotherapy were monitored daily. Lung function and a QOL measure (Chronic Respiratory Disease Questionnaire, CRDQ) were assessed across each period of treatment. Mean total sputum weights for each 4 week period did not differ significantly (CP 1251g, FP 1094g; p>0.3). Time spent performing physio each day was also similar (CP 29.9 mins, FP 26.2 mins, p>0.1). Lung function did not alter greatly across either method of therapy (mean initial FEV1 (L) 1.66, post CP 1.61, post FP 1.70). No clinically significant change was seen in the total CRDQ score or the individual domains of dyspnoea, emotional function, mastery or fatigue. We have shown that the VRPI flutter valve is as effective and takes no longer than conventional physiotherapy in aiding sputum clearance in these patients. It provides a useful and effective alternative to CP and may increase compliance in patients who have difficulty with conventional techniques.
Article
There is a paucity of data on incidence, prevalence and mortality associated with non-cystic fibrosis bronchiectasis. Using the Clinical Practice Research Datalink for participants registered between January 1, 2004 and December 31, 2013, we determined incidence, prevalence and mortality associated with bronchiectasis in the UK and investigated changes over time. The incidence and point prevalence of bronchiectasis increased yearly during the study period. Across all age groups, the incidence in women increased from 21.2 per 100 000 person-years in 2004 to 35.2 per 100 000 person-years in 2013 and in men from 18.2 per 100 000 person-years in 2004 to 26.9 per 100 000 person-years in 2013. The point prevalence in women increased from 350.5 per 100 000 in 2004 to 566.1 per 100 000 in 2013 and in men from 301.2 per 100 000 in 2004 to 485.5 per 100 000 in 2013. Comparing morality rates in women and men with bronchiectasis in England and Wales (n=11 862) with mortality rates in the general population from Office of National Statistics data showed that in women the age-adjusted mortality rate for the bronchiectasis population was 1437.7 per 100 000 and for the general population 635.9 per 100 000 (comparative mortality figure of 2.26). In men, the age-adjusted mortality rate for the bronchiectasis population was 1914.6 per 100 000 and for the general population 895.2 per 100 000 (comparative mortality figure of 2.14). Bronchiectasis is surprisingly common and is increasing in incidence and prevalence in the UK, particularly in older age groups. Bronchiectasis is associated with a markedly increased mortality.
Article
Physiotherapy is an important component of the management of patients with noncystic fibrosis bronchiectasis and chronic obstructive pulmonary disease (COPD), yet the types of interventions commonly utilised and measures of treatment efficacy are unclear. This study aimed to determine the current clinical practice of airway clearance therapy and exercise prescription in bronchiectasis and COPD. Two postal questionnaires were distributed to physiotherapists throughout Australia and New Zealand (n=120). Of the 120 questionnaires mailed in each study, 102 and 98 surveys were returned (a response rate of 85% and 82% respectively). The most commonly used airway clearance techniques for both conditions included active cycle of breathing technique, positioning, deep breathing exercises and positive expiratory pressure (PEP) therapy using Bottle PEP. Physical exercise was recommended by the majority of respondents for patients with bronchiectasis and COPD (98% and 100% respectively) with pulmonary rehabilitation ‘always’ prescribed (n=41, 39%). Respondents primarily used the Six-Minute Walk Test as a formal measure of exercise efficacy (n=71, 78%). This survey demonstrated that the most frequently employed airway clearance techniques were selected in similar proportions for both diseases. Assessment of exercise efficacy included measurements which are evaluation tools within pulmonary rehabilitation programs.
Article
Airway clearance techniques (ACTs) are recommended for patients with stable non-cystic fibrosis (non-CF) bronchiectasis, but the efficacy of oscillating positive expiratory pressure (PEP) therapy compared to other techniques has not been reviewed. A systematic review of studies was conducted in stable patients comparing the effect of oscillating PEP therapy to other ACTs or a control condition. Data were extracted related to sputum expectoration, lung function, gas exchange, quality of life (QOL), symptoms, and exacerbation rate. Seven studies were included with a total of 146 patients, with a mean (SD) PEDro score of 7(1). Oscillating PEP therapy enhanced sputum expectoration compared to no treatment, but has equivalent benefits as the active cycle of breathing technique with gravity-assisted drainage (mean difference [95% CI] -2.8 g [-8.8 to 3.2 g]). Oscillating PEP has a similar effect as other ACTs on dynamic lung volumes, gas exchange and breathlessness. Use of oscillating PEP improved disease-specific QOL (p < 0.001) and cough-related QOL (p < 0.002) compared to no treatment but did not reduce exacerbation rate. In conclusion, in stable non-CF bronchiectasis, oscillating PEP therapy is associated with improvement in sputum expectoration and QOL compared to no treatment. Compared to other ACTs, the effect upon sputum expectoration, lung function, gas exchange, and symptoms are equivalent. © The Author(s) 2014.
Article
This article presents an empirical study of an open educational course in an online peer-to-peer university (P2PU). P2PU is a nonprofit organization offering free educational opportunities. Focus is on how peers are part of creating course content in a Web 2.0 environment. Massive open online courses (MOOCs) have evolved into two different pedagogical directions: content-based xMOOCs and connectivist cMOOCs. cMOOCs emphasizing learning in networks developed informally, where learners are part of creating course content, resemble P2PU`s vision. We investigated processes of interaction in co-creation of tasks in an open educational course and what opportunities and challenges emerge. We employed template analysis for coding data. We report two different processes of interaction between users and organizers: problem identification and co-creation of tasks. This study contributes to understanding a new model of teaching and learning through scrutinizing participation in an open educational course and explores implications for the learning experience.